myelomic.blogspot.com myelomic.blogspot.com

MYELOMIC.BLOGSPOT.COM

Multiple Myeloma News

Multiple Myeloma News Articles. Monday, June 14, 2010. New drug: Pomalidomide Phase II results. From the Celgene web site:. Data from Pomalidomide Study in Refractory Multiple Myeloma Patients Presented at ASCO. Jun 05, 2010 - Celgene International Sàrl (NASDAQ: CELG) today announced results of a Phase II study of pomalidomide and dexamethasone in multiple myeloma patients who have failed both lenalidomide and bortezomib. Data were presented by Dr. Martha Lacy of the Mayo Clinic. Pomalidomide is an IMiDs...

http://myelomic.blogspot.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR MYELOMIC.BLOGSPOT.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.2 out of 5 with 10 reviews
5 star
8
4 star
0
3 star
0
2 star
0
1 star
2

Hey there! Start your review of myelomic.blogspot.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.4 seconds

FAVICON PREVIEW

  • myelomic.blogspot.com

    16x16

  • myelomic.blogspot.com

    32x32

CONTACTS AT MYELOMIC.BLOGSPOT.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Multiple Myeloma News | myelomic.blogspot.com Reviews
<META>
DESCRIPTION
Multiple Myeloma News Articles. Monday, June 14, 2010. New drug: Pomalidomide Phase II results. From the Celgene web site:. Data from Pomalidomide Study in Refractory Multiple Myeloma Patients Presented at ASCO. Jun 05, 2010 - Celgene International Sàrl (NASDAQ: CELG) today announced results of a Phase II study of pomalidomide and dexamethasone in multiple myeloma patients who have failed both lenalidomide and bortezomib. Data were presented by Dr. Martha Lacy of the Mayo Clinic. Pomalidomide is an IMiDs...
<META>
KEYWORDS
1 multiple myeloma news
2 press releases
3 about pomalidomide
4 about celgene
5 3 comments
6 2 comments
7 new drug zolinza
8 0 comments
9 hub=canadaamv2
10 ready
CONTENT
Page content here
KEYWORDS ON
PAGE
multiple myeloma news,press releases,about pomalidomide,about celgene,3 comments,2 comments,new drug zolinza,0 comments,hub=canadaamv2,ready,sleep diet details,4 comments,myeloma genome sequencing,revlimid survival statistics,dimopoulos ma,chen c,attal m
SERVER
GSE
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Multiple Myeloma News | myelomic.blogspot.com Reviews

https://myelomic.blogspot.com

Multiple Myeloma News Articles. Monday, June 14, 2010. New drug: Pomalidomide Phase II results. From the Celgene web site:. Data from Pomalidomide Study in Refractory Multiple Myeloma Patients Presented at ASCO. Jun 05, 2010 - Celgene International Sàrl (NASDAQ: CELG) today announced results of a Phase II study of pomalidomide and dexamethasone in multiple myeloma patients who have failed both lenalidomide and bortezomib. Data were presented by Dr. Martha Lacy of the Mayo Clinic. Pomalidomide is an IMiDs...

INTERNAL PAGES

myelomic.blogspot.com myelomic.blogspot.com
1

Multiple Myeloma News: Multiple Myeloma Genomics Initiative Sequences Myeloma Genomes

http://myelomic.blogspot.com/2009/07/multiple-myeloma-genomics-initiative.html

Multiple Myeloma News Articles. Monday, July 27, 2009. Multiple Myeloma Genomics Initiative Sequences Myeloma Genomes. Myeloma Research Foundation (MMRF) and Multiple Myeloma Research Consortium (MMRC) announced the MMRC Multiple Myeloma Genomics Initiative has completed the sequencing of the first multiple myeloma whole genomes. This is the first time multiple myeloma whole genomes have been sequenced and will be used to identify key targets for new treatments. Through its extraordinary generosity and v...

2

Multiple Myeloma News: Revlimid survival statistics

http://myelomic.blogspot.com/2009/08/revlimid-survival-statistics.html

Multiple Myeloma News Articles. Wednesday, August 26, 2009. Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma. Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece. PMID: 19626046 [PubMed - as supplied by publisher]. Posted by gwg at 3:59 PM. View my complete profile. New Antibiotics May Target Cancer-Causing Proteins. Pesticide link to MGUS.

3

Multiple Myeloma News: New Drug Zolinza

http://myelomic.blogspot.com/2010/01/new-drug-zolinza.html

Multiple Myeloma News Articles. Wednesday, January 06, 2010. The 2009 American Society of Hematology (ASH) meeting showcased presentations on Zolinza (vorinostat), a histone deacetylase inhibitor developed by Merck Pharmaceuticals. Zolinza alters the way a cancer cell’s DNA creates proteins. This can slow down cell proliferation, minimize mutations in DNA and control cell death. Zolinza is being investigated in combination with Revlimid and Velcade. Posted by gwg at 10:34 AM. View my complete profile.

4

Multiple Myeloma News: Dr. Ken Anderson Myeloma Update

http://myelomic.blogspot.com/2009/10/dr-ken-anderson-myeloma-update.html

Multiple Myeloma News Articles. Wednesday, October 07, 2009. Dr Ken Anderson Myeloma Update. Don't miss Dr. Ken Anderson's Myeloma update on October 29. Https:/ www.rmei.com/LLSmyeloma/event.html. Information available at the Lymphoma and Leukemia society. Posted by gwg at 9:59 PM. View my complete profile. MMRF new web site. Sleep to lose weight. FDA grants orphan drug status to Keryx. Health info too small to read. New Antibiotics May Target Cancer-Causing Proteins.

5

Multiple Myeloma News: New drug: Pomalidomide Phase II results

http://myelomic.blogspot.com/2010/06/new-drug-pomalidomide-phase-ii-results.html

Multiple Myeloma News Articles. Monday, June 14, 2010. New drug: Pomalidomide Phase II results. From the Celgene web site:. Data from Pomalidomide Study in Refractory Multiple Myeloma Patients Presented at ASCO. Jun 05, 2010 - Celgene International Sàrl (NASDAQ: CELG) today announced results of a Phase II study of pomalidomide and dexamethasone in multiple myeloma patients who have failed both lenalidomide and bortezomib. Data were presented by Dr. Martha Lacy of the Mayo Clinic. Pomalidomide is an IMiDs...

UPGRADE TO PREMIUM TO VIEW 15 MORE

TOTAL PAGES IN THIS WEBSITE

20

LINKS TO THIS WEBSITE

myelomahope.blogspot.com myelomahope.blogspot.com

Myeloma Hope: 08/01/2014 - 09/01/2014

http://myelomahope.blogspot.com/2014_08_01_archive.html

Saturday, August 2, 2014. Today I felt much more like myself, even went for a stroll and mowed a little bit of the lawn. Temps are normal and the pulse oximeter regularly shows numbers in the high 90's. The pneumonia is on the run, and I won't post any more about it here unless there is a dramatic reversal. Links to this post. Friday, August 1, 2014. Right now my temp is generally around normal, which is a definite improvement, and I have some appetite. However, blood oxygen isn't much better than it...

myelomahope.blogspot.com myelomahope.blogspot.com

Myeloma Hope: Seven Great Years

http://myelomahope.blogspot.com/2015/04/seven-great-years.html

Friday, April 10, 2015. The image shows a cross-section of my body laying on my back, the view slicing through both arms and the chest, including the lungs (black) and with the T5 vertebra at the bottom. The brightest spot is the myeloma, just above the spinal cord in the vertebra. Dr L called this evening and we had a wonderful conversation. Some points:. Either way, this lesion has to be treated, both to protect the spine and to keep the new clone from taking over. This would be the most conservative a...

myelomahope.blogspot.com myelomahope.blogspot.com

Myeloma Hope: 02/01/2015 - 03/01/2015

http://myelomahope.blogspot.com/2015_02_01_archive.html

Tuesday, February 24, 2015. FDA Approves Farydak (Panobinostat). This is a victory for myeloma patients, and perhaps for all patients facing a life-threatening disease. Farydak (panobinostat) is a new oral drug approved specifically for use with bortezomib (Velcade) and dexamethasone to treat patients who have previously undergone at least two prior regimens, including Velcade and an immunomodulatory agent (thalidomide, Revlimid, or Pomalyst). It comes with this boxed warning:. I congratulate the FDA on ...

myelomahope.blogspot.com myelomahope.blogspot.com

Myeloma Hope: Dr Martha Q Lacy, Woman of the Year

http://myelomahope.blogspot.com/2015/04/dr-martha-q-lacy-woman-of-year.html

Sunday, April 5, 2015. Dr Martha Q Lacy, Woman of the Year. The Leukemia and Lymphoma Society (LLS) combats all blood cancers, including myeloma, supporting research as well as the patients themselves. Every year the LLS holds a Woman (and Man) Of The Year competition, to raise funds and to honor the nominees. Dr Lacy is a nominee this year. Martha Q Lacy, M.D. Recommended reading: Here is a copy of a letter that we received from her a few days ago: lacyletter.html. Subscribe to: Post Comments (Atom).

myelomahope.blogspot.com myelomahope.blogspot.com

Myeloma Hope: Beta Blockers May Improve Myeloma Survival

http://myelomahope.blogspot.com/2014/12/beta-blockers-may-improve-myeloma.html

Tuesday, December 9, 2014. Beta Blockers May Improve Myeloma Survival. ASH Monday, December 8, 2014. Results: The five-year overall survival (OS) for myeloma patients taking beta blockers was about 62%, contrasted with OS of 47% for those not taking beta blockers. How much is enough or too much? Is it really the beta blocker, or is it the underlying condition or lifestyle that prompted the doctor to prescribe the beta blocker? There is work to be done. Caution: Beta blockers are contraindicated for some ...

myelomahope.blogspot.com myelomahope.blogspot.com

Myeloma Hope: New Regimen

http://myelomahope.blogspot.com/2015/04/ixazomib-study.html

Monday, April 13, 2015. After seven years my myeloma has finally made an end run around my dear friend Pomalyst and found a way to hurt me. The previous post. Shows the PET scan of the hot little lesion that threatens to hurt my spine. Pomalyst is still working, you might say, because the blood markers IgG and M-Spike continue to be stable. Nevertheless the T5 lesion appeared, so something must change soon, and I am enrolling in a study of a new drug. Blood draw for who knows what. A fond farewall to Pom...

myelomahope.blogspot.com myelomahope.blogspot.com

Myeloma Hope: Pomalyst Study Ends

http://myelomahope.blogspot.com/2015/02/pomalyst-study-ends.html

Saturday, February 14, 2015. But I'm still on Pomalyst, 2 mg daily with no days off, thanks to insurance. Somewhat to our surprise, Mayo Clinic abruptly cancelled my participation in the study at the visit which ended my 89th 28-day cycle. As far as I know the drug manufacturer, Celgene, was prepared to continue the study, but Mayo explained that they needed the resources elsewhere. At a gluten-free restaurant called Nourish in Gilbert, AZ. That dressing is lime-based, perfect for the salmon and the salad.

myelomahope.blogspot.com myelomahope.blogspot.com

Myeloma Hope: End of Cycle Two

http://myelomahope.blogspot.com/2015/06/end-of-cycle-two.html

Tuesday, June 23, 2015. End of Cycle Two. Tuesday, June 16, 2015:. I have been on a trial of a new oral regimen for two months now, and I am a little disappointed to report that there is no significant change in my numbers. My IgG dropped from 1230 to 1190 mg/dL this month, and M-Spike from 1.2 to 1.1 g/dL, but both of those values are well within their recent variability. The good news is that the numbers didn't go up! In the meantime I am physically quite active with. Running, cycling, and lawn mowing,...

myelomahope.blogspot.com myelomahope.blogspot.com

Myeloma Hope: Day One of Cycle One

http://myelomahope.blogspot.com/2015/04/day-one-of-cycle-one.html

Wednesday, April 22, 2015. Day One of Cycle One. I'm now on a study of a new drug (Primary drug), along with dexamethasone (Dex). I take both once per week for three weeks, then one week off from the Primary drug, then repeat that cycle. Dex with the evening meal: ten tiny 4-mg tablets = 40 mg. Wait an hour and a half after finishing the meal and my one beer. I asked - the pharmacist said beer is food. Tsk. Take a Kytril tablet (Granisetron) against possible nausea. Wait another half hour. My biggest con...

myelomahope.blogspot.com myelomahope.blogspot.com

Myeloma Hope: 03/01/2015 - 04/01/2015

http://myelomahope.blogspot.com/2015_03_01_archive.html

Wednesday, March 11, 2015. A couple of weeks ago Mayo sent me a cube-shaped box (kit), perhaps 10 inches on all sides, containing five vials, instructions, a FedEx overnight return label, and a freezable gel block about the size of a pound of hamburger. Instructions said to do the draw on March 9. Just to check, I stopped in at the clinic a week or so ago, showed them the box, and asked about the kit draw. "Oh yeah, we do that all the time," was the response. I froze the gel. Links to this post. I have b...

UPGRADE TO PREMIUM TO VIEW 7 MORE

TOTAL LINKS TO THIS WEBSITE

17

OTHER SITES

myelomemultiple.fr myelomemultiple.fr

Janssen - Myélome Multiple, parlons-en !

MyéloME MULTIPLE , PARLONS-EN! On vous accompagne tout au long de la maladie. La prise en charge du Myélome Multiple. Les symptômes du Myélome Multiple. La prise en charge des complications. Qu'est-ce que le Myélome Multiple. Les examens du diagnostic. Vivre avec la maladie. La rédaction de directives anticipées. Coordination des soins au sein du corps médical. Impact sur votre vie professionnelle. L’accès à vos informations médicales. Congés pour les aidants. Vous êtes ici :. Vivre avec la maladie.

myelomemultiple.org myelomemultiple.org

Hébergement, enregistrement de nom de domaine et services internet par 1&1 Internet

CE NOM DE DOMAINE VIENT D'ÊTRE ENREGISTRÉ POUR L'UN DE NOS CLIENTS. Avez-vous besoin, vous aussi, d'une VRAIE solution d'hébergement VRAIMENT accessible? Vous propose les solutions les moins chères du Net pour réaliser votre site web en toute simplicité, que vous soyez débutant ou expérimenté. Des solutions d'hébergement complètes. Une large gamme de logiciels offerts. Un espace de configuration intuitif. Une assistance technique efficace. Aucun engagement de durée. Garantie satisfait ou remboursé.

myelomeningocele.blogspot.com myelomeningocele.blogspot.com

Myelomeningocele | Spina Bifida

Thursday, July 26, 2007. Research Blog Up and Running. There are 84 citations plus abstracts listed in the Research Blog located at http:/ spina-bifida-bibliography.blogspot.com/. More added weekly, sometimes daily. Check it out and let me know what you think. Wednesday, July 18, 2007. Updates to Web Site - Equipment for Infants and Toddlers. Added several photos of equipment for infants and toddlers with spina bifida including special chairs/seating. We've also added two new pages of links:. And the oth...

myelomeningoceleawareness.com myelomeningoceleawareness.com

myelomeningoceleawareness.com -&nbspmyelomeningoceleawareness Resources and Information.

myelomeningoceleawareness.org myelomeningoceleawareness.org

myelomeningoceleawareness.org -&nbspmyelomeningoceleawareness Resources and Information.

myelomic.blogspot.com myelomic.blogspot.com

Multiple Myeloma News

Multiple Myeloma News Articles. Monday, June 14, 2010. New drug: Pomalidomide Phase II results. From the Celgene web site:. Data from Pomalidomide Study in Refractory Multiple Myeloma Patients Presented at ASCO. Jun 05, 2010 - Celgene International Sàrl (NASDAQ: CELG) today announced results of a Phase II study of pomalidomide and dexamethasone in multiple myeloma patients who have failed both lenalidomide and bortezomib. Data were presented by Dr. Martha Lacy of the Mayo Clinic. Pomalidomide is an IMiDs...

myelominfo24.eu myelominfo24.eu

 Myelom Informationen - Multiples Myelom - Plasmozytom 

Für Betroffene von Betroffenen. Multiples Myelom / Plasmozytom Informationsmappe. Meine Informationsmappe ist leider ab sofort nicht mehr. Erhältlich ( die Bestellformulare funktionieren also nicht mehr. Falls Fragen bestehen oder Betroffene Informationen miteinander austauschen wollen, verweise ich gerne auf meine Facebook-Seite: https:/ www.facebook.com/myelominfo24. Alles Gute für Ihre Gesundheit. Mit herzlichem Gruß, Jörg Stephan. Diagnose Multiples Myelom / Plasmozytom? Da Sie diese Webseite über da...

myelomshs.de myelomshs.de

http://www.myelomshs.de/

Your browser does not support framesets. Please click here to be redirected to the final page.

myelomtage.de myelomtage.de

Myelomtage 2017

Im Neuenheimer Feld 410. 22 September 2017 mehr. 23 September 2017 mehr. Hörsaal der Medizinischen Klinik. Im Neuenheimer Feld 410. Prof Dr. med. Hartmut Goldschmidt. Prof Dr. med. Jens Hillengaß. PD Dr med. Marc-Steffen Raab. Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg. Im Neuenheimer Feld 410. Prof Dr. med. Hartmut Goldschmidt. Prof Dr. med. Jens Hillengaß. PD Dr med. Marc-Steffen Raab. Bei Fragen kontaktieren Sie bitte Frau Annette Hluzek unter folgenden Kontaktdaten:.

myelon.de myelon.de

Spezialsuchmaschine LuMriX.net GmbH

myelon.info myelon.info

TIETOA HYDROKEFALIASTA JA MMC:STÄ

TIETOA HYDROKEFALIASTA JA MMC:STÄ. Suomen CP-liitto palvelee mys MMC- ja hydrokefaliavammaisia henkilit, heidn perheitn ja omaisiaan sek kaikkia MMC- ja hydrokefaliavammasta kiinnostuneita. MMC- ja hydrokefaliatoiminta vlittihmisilletietoa ja tukea. Toiminnan tarkoituksena on saattaa yhteen ihmisi, joilla on elmssn samankaltaisia haasteita ja tukea ihmisi kohtielm josta voi nauttia. Kun tarvitset tietoa tai tukea, ota yhteytt! Yhteys MMC- ja hydrokefaliatoimintaan:. 169; Suomen CP-liitto ry.